Clinical Trial Update: A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating pemetrexed plus oxaliplatin as first-line therapy for advanced gastric carcinoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Carcinoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Gastric Carcinoma | Phase 2 | Status: COMPLETED